Highlights d Screen of kinase inhibitors identifies Yck2 kinase as a promising antifungal target d Clinical echinocandin resistance is reversed by pyrazolopyridine Yck2 inhibitors d Combination treatment eradicates fungus while sparing cocultured human cells d Genetic depletion of YCK2 markedly impairs Candida